From: The expression and role of tyrosine kinase ETK/BMX in renal cell carcinoma
Clinical data | n | ETK | Pvalue | |
---|---|---|---|---|
High expression | Low expression | |||
 |  | (staining index ≥ 2) | (staining index<2) |  |
Normal renal tissus | 30 | 2 | 28 | <0.001 |
RCC tissues | 90 | 56 | 34 | Â |
Age (years) | Â | Â | Â | 0.788 |
  ≤50 | 28 | 16 | 12 |  |
  50~70 | 50 | 32 | 18 |  |
  ≥70 | 12 | 8 | 4 |  |
Gender | Â | Â | Â | 0.322 |
  Male | 55 | 32 | 23 |  |
  Female | 35 | 24 | 11 |  |
Position of the tumor | Â | Â | Â | 0.351 |
  Upper pole | 36 | 20 | 16 |  |
  Central part | 19 | 11 | 8 |  |
  Lower pole | 35 | 25 | 10 |  |
TNM stage | Â | Â | Â | 0.005 |
  I + II | 67 | 36 | 31 |  |
  III + IV | 23 | 20 | 3 |  |
Grade (Differentiation level) | Â | Â | Â | 0.001 |
  Well | 66 | 34 | 32 |  |
  Moderately and poorly | 24 | 22 | 2 |  |
Metastasis | Â | Â | Â | 0.002 |
  No | 72 | 39 | 33 |  |
  Yes | 18 | 17 | 1 |  |